Why the study?
Does rivaroxaban once a day improve adherence to therapy and stroke prevention in patients with atrial fibrillation compared to vitamin K antagonists?
Population
Patients with atrial fibrillation (AF) with moderate or high risk of stroke
Comparison
Non-vitamin K antagonist oral anticoagulants… vs Vitamin K antagonists (e.g., warfarin)
Design
Review
Authors
Loading...
Once-daily rivaroxaban may aid adherence in AF; hypothesis-generating and requires randomized trials before practice change.
Does rivaroxaban once a day improve adherence to therapy and stroke prevention in patients with atrial fibrillation compared to vitamin K antagonists?
Once-daily dosing of non-vitamin K antagonist oral anticoagulants like rivaroxaban may improve medication adherence and stroke prevention outcomes in patients with atrial fibrillation.
С. Г. Канорский (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: